Dose-to-dose variations with single packages of counterfeit medicines and adulterated dietary supplements as a potential source of false negatives and inaccurate health risk assessments

Journal of Pharmaceutical and Biomedical Analysis

Volumn 89, Issue , 2014, Pages 158-165

  Venhuis, B J ^a   Zwaagstra, M E ^b   Keizers, P H J ^a   de Kaste, D ^a  

^a NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^b Dutch Customs Laboratory   (Netherlands)

Author keywords

Benzyl sibutramine; Counterfeit medicines and adulterated dietary supplements; Dose to dose variability; Sibutramine analogues; UPLC QTOF MS MS

Indexed keywords

BENZYL SIBUTRAMINE; COUNTERFEIT DRUG; N DESMETHYL SIBUTRAMINE; N,N DIDESMETHYL SIBUTRAMINE; SIBUTRAMINE; SILDENAFIL; UNCLASSIFIED DRUG;

ADULTERATED DIETARY SUPPLEMENT; ARTICLE; BLISTER PACK; COFFEE; DIET SUPPLEMENTATION; DRUG CAPSULE; DRUG IMPURITY; DRUG PACKAGING; DRUG QUALITY; HEALTH HAZARD; HERBAL MEDICINE; HUMAN; PRIORITY JOURNAL; QUALITY CONTROL; RISK ASSESSMENT; WEIGHT REDUCTION;

BENZYL-SIBUTRAMINE; COUNTERFEIT MEDICINES AND ADULTERATED DIETARY SUPPLEMENTS; DOSE-TO-DOSE VARIABILITY; SIBUTRAMINE ANALOGUES; UPLC-QTOF-MS/MS;

COFFEE; COUNTERFEIT DRUGS; DIETARY SUPPLEMENTS; DRUG CONTAMINATION; FALSE NEGATIVE REACTIONS; PIPERAZINES; PURINES; RISK; RISK ASSESSMENT; SULFONES;

EID: 84888393580     PISSN: 07317085     EISSN: 1873264X     Source Type: Journal    
DOI: 10.1016/j.jpba.2013.10.038     Document Type: Article

References (15)

1. Fittler A., Lankó E., Brachmann B., Botz L. Behaviour analysis of patients who purchase medicines on the Internet: can hospital pharmacists facilitate online medication safety?. Eur. J. Hosp. Pharm.: Sci. Pract. 2013, 20:8-12.
2. Jackson G., Patel S., Khan S. Assessing the problem of counterfeit medications in the United Kingdom. Int. J. Clin. Pract. 2012, 66:241-250.
3. Orizio G., Merla A., Schulz P.J., Gelatti U. Quality of online pharmacies and websites selling prescription drugs: a systematic review. J. Med. Internet Res. 2011, 13:e74.
4. Cabezas M.D., Piqueras A.J. MEDICRIME: the international convention of the Council of Europe as a tool to combat counterfeit medicines. Pharm. Policy Law 2011, 13:41-55.
5. Lee Y.C., Kim B.S., Yun E.S., Kim S.D., Chang M.S., Park Y.A., Shin Y., Jung S.O., Lee J.I., Chae Y.Z. Monitoring of forbidden medicines as adulterants in dietary supplements marketed online by HPLC and ESI-tandom mass spectrometry. Korean J. Food Sci. Technol. 2012, 44:148-154.
6. Patel D.N., Li L., Kee C.L., Ge X., Low M.Y., Koh H.L. Screening of synthetic PDE-5 inhibitors and their analogues as adulterants: analytical techniques and challenges. J. Pharm. Biom. Anal. 2013, (in press).
7. Venhuis B.J., de Kaste D. Towards a decade of detecting new analogues of sildenafil, tadalafil and vardenafil in food supplements: a history, analytical aspects and health risks. J. Pharm. Biomed. Anal. 2012, 69:196-208.
8. Singh S., Prasad B., Savaliya A.A., Shah R.P., Gohil V.M., Kaur A. Strategies for characterizing sildenafil, vardenafil, tadalafil and their analogues in herbal dietary supplements, and detecting counterfeit products containing these drugs. Trends Anal. Chem. 2009, 28:13-28.
9. Vredenbregt M.J., Blok-Tip L., Hoogerbrugge R., Barends D.M., De Kaste D. Screening suspected counterfeit Viagra and imitations of Viagra with near-infrared spectroscopy. J. Pharm. Biomed. Anal. 2006, 40:840-849.
10. Mans D.J., Gucinski A.C., Dunn J.D., Gryniewicz-Ruzicka C.M., Mecker-Pogue L.C., Kao J.L.F., Ge X. Rapid screening and structural elucidation of a novel sibutramine analogue in a weight loss supplement: 11-desisobutyl-11-benzylsibutramine. J. Pharm. Biomed. Anal. 2013, 83:122-128.
11. Edison S.E., Gratz S.R., Gamble B.M., Mohrhaus A.S. LC-MS/MS method for sibutramine and related compounds. FDA Lab. Inf. Bull. 2010, 4477:1-10.
12. Song F., Monroe D., El-Demerdash A., Palmer C. Screening for multiple weight loss and related drugs in dietary supplement materials by flow injection tandem mass spectrometry and their confirmation by liquid chromatography tandem mass spectrometry. J. Pharm. Biom. Anal. 2014, 88:136-143.
13. Jeffery J.E., Kerrigan F., Miller T.K., Smith G.J., Tometzki G.B. Synthesis of sibutramine, a novel cyclobutylalkylamine useful in the treatment of obesity, and its major human metabolites. J. Chem. Soc. - Perkin Trans. 1996, 1:2583-2589.
14. Han Z., Krishnamurthy D., Fang Q.K., Wald S.A., Senanayake C.H. New resolution approach for large-scale preparation of enantiopure didesmethylsibutramine (DDMS). Tetrahedron Asymm. 2003, 14:3553-3556.
15. Saranadasa H. The square root of N plus one sampling rule: how much confidence do we have?. Pharm. Technol. 2003, 27:50-62.